Marlene C. Hinton

Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression

Dewan Md Sakib Hossain, Sarah Javaid, Mingmei Cai et al. · Journal of Clinical Investigation · 2018 · 218 citations · Full text

Medicine, Immunology, Oncology +17

Discovery of 1-(1<i>H</i>-Pyrazolo[4,3-<i>c</i>]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers

Jongwon Lim, Elizabeth H. Kelley, Joey L. Methot et al. · Journal of Medicinal Chemistry · 2016 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors

Weisheng Zhang, Brian B. Haines, Clay L. Efferson et al. · Translational Oncology · 2012 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16

High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide

Amy D. Guertin, Jennifer O’Neil, Alexander Stoeck et al. · Molecular Cancer Therapeutics · 2016 · 20 citations · Full text

Medicine, Oncology, Pharmacology +14